BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33901252)

  • 1. Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance.
    Popowicz N; Cheah HM; Gregory C; Miranda A; Dick IM; Lee YCG; Creaney J
    PLoS One; 2021; 16(4):e0250628. PubMed ID: 33901252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
    Lee YS; Nam HS; Lim JH; Kim JS; Moon Y; Cho JH; Ryu JS; Kwak SM; Lee HL
    BMC Cancer; 2017 Aug; 17(1):557. PubMed ID: 28830378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.
    Takeuchi E; Okano Y; Machida H; Atagi K; Kondou Y; Kadota N; Hatakeyama N; Naruse K; Shinohara T
    Cancer Immunol Immunother; 2022 Feb; 71(2):365-372. PubMed ID: 34170380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
    Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
    Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can LENT Prognostic score (LDH, ECOG performance score, blood neutrophil/lymphocyte ratio, tumor type) change the clinical approach in malignant pleural effusion?
    Gayaf M; Anar C; Canbaz M; Doğan Bİ; Erbaycu AE; Güldaval F
    Tuberk Toraks; 2021 Jun; 69(2):133-143. PubMed ID: 34256503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important prognostic factors for survival in patients with malignant pleural effusion.
    Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
    BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
    Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
    Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleural Neutrophil-to-Lymphocyte Ratio May Be Associated With Early Disease Progression in Stage IV Non-small Cell Lung Cancer.
    Lim JU; Yeo CD; Kim HW; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Lee SH
    In Vivo; 2020; 34(4):2179-2185. PubMed ID: 32606202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Neutrophil to Lymphocyte Ratio May Predict Benefit from Chemotherapy in Lung Cancer.
    Liu D; Jin J; Zhang L; Li L; Song J; Li W
    Cell Physiol Biochem; 2018; 46(4):1595-1605. PubMed ID: 29694985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
    PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.
    Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
    Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migrated T lymphocytes into malignant pleural effusions: an indicator of good prognosis in lung adenocarcinoma patients.
    Nieto JC; Zamora C; Porcel JM; Mulet M; Pajares V; Muñoz-Fernandez AM; Calvo N; Espinosa I; Pascual-García M; Bielsa S; Vidal S
    Sci Rep; 2019 Feb; 9(1):2996. PubMed ID: 30816121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
    Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
    Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
    Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
    Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients.
    Miyamoto R; Inagawa S; Sano N; Tadano S; Adachi S; Yamamoto M
    Eur J Surg Oncol; 2018 May; 44(5):607-612. PubMed ID: 29478743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in patients with malignant pleural effusion: Is it possible to predict mortality in patients with good performance status?
    Abrao FC; Peixoto RD; de Abreu IR; Janini MC; Viana GG; de Oliveira MC; Younes RN
    J Surg Oncol; 2016 Apr; 113(5):570-4. PubMed ID: 26751412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.
    Burrows CM; Mathews WC; Colt HG
    Chest; 2000 Jan; 117(1):73-8. PubMed ID: 10631202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From Six UK Centers.
    Bibby AC; Clive AO; Slade GC; Morley AJ; Fallon J; Psallidas I; Pepperell JCT; Slade MG; Stanton AE; Rahman NM; Maskell NA
    Chest; 2015 Jul; 148(1):235-241. PubMed ID: 25429399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.
    Kao SC; Vardy J; Chatfield M; Corte P; Pavlakis N; Clarke C; van Zandwijk N; Clarke S
    Clin Lung Cancer; 2013 Jan; 14(1):70-7. PubMed ID: 22658812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.